Mergers and Acquisitions

Clinical Stage Biopharma Co. Sienna Hits Ch. 11 In Del.

Sienna Biopharmaceuticals Inc., a research and development outfit that focuses on dermatology products, filed for bankruptcy Monday in Delaware to stave off a looming default on roughly $10 million in debt. ...read more